HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide
Authors
Keywords
myeloma, CD44, miR-9–5p, IGF2BP3, lenalidomide
Journal
Oncotarget
Volume 6, Issue 31, Pages -
Publisher
Impact Journals, LLC
Online
2015-09-30
DOI
10.18632/oncotarget.5290

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.